Interested in Participating in a Clinical Trial?

Velocity News

Featured news

Velocity Clinical Research acquired by GHO signaling evolution of clinical trial site industry

04/08/2021

Latest Posts

Velocity Clinical Research acquires two new sites, signaling commitment to diversifying patient recruitment

03/17/2021

Velocity Executive Memo Series, Vol. 2

By Dr. Paul Evans | 03/01/2021

What do teenagers and over 65s have in common?

Velocity Executive Memo Series, Vol. 1

By Dr. Paul Evans | 02/01/2021

COVID-19, Our work is not done.

Velocity Clinical Research acquires eStudySite in San Diego

11/02/2020 | Acquisitions

Velocity Acquires Omega Medical Research and Buynak Clinical Research, Expanding Its Reach to All Four Continental U.S. Time Zones

06/08/2020

Velocity Acquires Omega Medical Research and Buynak Clinical Research, Expanding Its Reach to All Four Continental U.S. Time Zones

Spotlight on Real World Challenges Facing Virtual Trials - Interview with CEO, Paul Evans

06/08/2020

“We’re still living with this black swan moment, this pandemic,” says Evans. While the industry has adapted and embraced new technologies and ideas, there’s a chance the changes won’t stick, Evans says. “Memories can be short, and people can revert back to type, and the [clinical trial industry] isn’t historically quick to adapt. I hope we don’t slide back into our old ways,” he says in our June 4, 2020 interview.

Durham startup Velocity Clinical doubles in size with latest acquisitions

11/06/2019

Velocity Clinical Research is doubling in size with its latest acquisitions announced today. The Durham-based clinical site organization has acquired Advanced Clinical Research (ACR) and Rapid Medical Research (RMR), adding six sites to the existing organization.

Velocity Clinical Doubles its Size with New Acquisitions including Advanced Clinical Research and Rapid Medical Research and Evidences Commitment to Vision

11/06/2019

The Clinical investigational site market continues to get more interesting by the day. Private equity-backed Velocity Clinical Research, led by industry veteran Paul Evans, acquired more regional clinical sites, adding six of them while in the process, expanding its footprint to 10 sites in seven states. The company is executing to a strategic vision for a high impact, scaled out clinical investigational site operation that over time could rival some contract research organizations.

Velocity COVID-19 message from the CEO

By Dr. G Paul Evans | 11/06/2019

People on the Move: Outsourcing-Pharma roundup August ‘19 -- Melissa Holbrook

09/05/2019

Velocity Clinical Research expanded its senior management team this month with the addition of Melissa Holbrook as VP, Operations

Durham startup Velocity Clinical adds new exec, forecasts doubling in size by year-end

09/04/2019

With plans to double in size by the year’s end, Velocity Clinical Research is adding to its executive team to keep up with its exponential growth.

Durham clinical company bolsters C-suite for 'growth spurt'

09/03/2019

Following its launch-year acquisitions, Velocity Clinical Research is shuffling its executive team to prepare for an impending "growth spurt."

Sponsors Want to Hear from Sites—With Evidence

09/03/2019

Join Melissa Holbrook at the ACRP Southeast Regional Conference in Durham, NC, October 3-4 for a panel discussion on the importance of a great CRO and site relationship.

Velocity Clinical Research Snags Industry Expert Melissa Holbrook for New VP Operations Position

08/29/2019

Velocity Clinical Research is delighted to announce that its senior management team is expanding again this year. Melissa Holbrook joins the Velocity Clinical team as VP Operations, and will be responsible for clinical operations at all of Velocity’s sites.

Durham clinical research company expands on West Coast

05/28/2019

Just months after launching, a new Durham clinical trial organization has already added a new site to its portfolio – the first of many in the company's growth plan.

Velocity Clinical expands its footprint yet again with 4th acquisition this year

05/28/2019

The Durham-based company has acquired its fourth site in almost as many months, adding a new state-of-the-art clinical research facility in Oregon.

Velocity Clinical Research adds new OR-based site

05/28/2019

Following its formal launch in February 2019, Velocity Clinical Research adds to its site network to tap into a new patient population, says CEO.

Velocity Clinical Research: The Value-Added Site Organization Designed to Raise the Research Bar

04/20/2019

Velocity Clinical Research recently announced important additions to its senior leadership team including: Jeffrey Jensen, Senior Vice President, Operations; Jamie Wilkerson, Vice President, Finance and Craig M. Koch, Vice President, Business Development.

Durham-based Velocity Clinical’s new management team

04/10/2019

Velocity Clinical Research is hoping to disrupt the quickly changing business of clinical trails and patient recruitment. Now it’s got its A-team to help it do just that.

Velocity Clinical Research snares $20M-plus in funding, acquires 3 research sites

02/13/2019

Velocity Clinical Research, a Durham, North Carolina-based patient recruitment specialist, used $20 million from a recent fundraising to acquire its first three research sites.

Gaining Velocity: New site organization aims to solve age-old problem

02/07/2019

Velocity Clinical Research officially launches following the acquisition of three US-based sites – with plans to expand globally and become one of the leading site groups in the world, says CEO.

Velocity Clinical Research Raises the Bar for Patient Recruitment

02/06/2019

Velocity Clinical Research, a clinical trials site organization focused on setting a new bar for providing rapid data delivery with the highest level of patient care, has announced it has acquired its first three research sites in the USA.

Durham-based Velocity Clinical raises more than $20M to purchase 3 research sites

02/05/2019

The business of clinical trials and patient recruitment is changing quickly, and Velocity Clinical Research is hoping to capitalize on that.